Cardiovascular Diabetology · 2022 · 197 citations · 40 references
MedicineCardiologyInternal MedicineClinical CardiologyPreventive CardiologyRisk AssessmentCardiac Risk AssessmentCardiovascular DiseaseCardiovascular RiskCoronary Artery DiseaseInsulin ResistanceIschemic Heart DiseaseAtherosclerosis RiskAtherosclerotic Risk AssessmentCardiometabolic DiseaseCardiovascular Risk DetectionCardiovascular Risk MarkersCoronary Ct AngiographyCoronary Heart Disease EpidemiologyMetabolic Risk Assessment
BACKGROUND: Insulin resistance (IR), endothelial dysfunction, inflammation, glucose and lipid metabolism disorders, and thrombosis are believed involved in coronary heart disease (CHD) and non-alcoholic fatty liver disease (NAFLD). Triglyceride-glucose (TyG) index, a new IR indicator, is correlated with NAFLD occurrence and severity, but its relationship with CHD risk remains unclear. This study investigated the correlation between TyG index and CHD risk among NAFLD patients. METHODS: This cross-sectional study included 424 patients with NAFLD and chest pain in the Department of Cardiology, The Second Hospital of Shanxi Medical University, from January 2021 to December 2021. The TyG index was calculated and coronary angiography performed. All individuals were divided into NAFLD + CHD and NAFLD groups and then by TyG index level. The t-test, Mann-Whitney U-test, or one-way analysis of variance compared differences in continuous variables, while the chi-square test or Fisher's exact test compared differences in categorical variables. Logistic regression analysis determined the independent protective or hazardous factors of NAFLD with CHD. The receiver operating characteristic curve evaluated the ability of different TyG index rule-in thresholds to predict CHD. The relationship between Gensini score and TyG index was evaluated using linear correlation and multiple linear regression. RESULTS: CHD was detected in 255 of 424 patients. Compared to NAFLD group, multivariate logistic regression showed that TyG index was a risk factor for CHD among NAFLD patients after adjustment for age, sex, hypertension, and diabetes mellitus with the highest odds ratio (OR, 2.519; 95% CI, 1.559-4.069; P < 0.001). TG, low-density lipoprotein cholesterol, FBG and TYG-body mass index were also risk factors for CHD among NAFLD patients. High-density lipoprotein cholesterol level was a protective factor for CHD events in patients with NAFLD. In an in-depth analysis, multivariate logistic regression analysis showed that each 1-unit increase in TyG index was associated with a 2.06-fold increased risk of CHD (OR, 2.06; 95% CI, 1.16-3.65; P = 0.013). The multifactor linear regression analysis showed each 0.1-unit increase in TyG in the NAFLD-CHD group was associated with a 2.44 increase in Gensini score (β = 2.44; 95% CI, 0.97-3.91; P = 0.002). CONCLUSIONS: The TyG index was positively correlated with CHD risk in NAFLD patients and reflected coronary atherosclerosis severity.
40
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Juhani Knuuti, William Wijns, Antti Saraste et al. · European Heart Journal · 2019 · 7.1K citations · Full text
Fernando Guerrero‐Romero, Luis E. Simental‐Mendía, Manuel González-Ortı́z et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 2.3K citations · Full text
Medicine, Endocrinology, Diabetology +15
Jan Borén, M. John Chapman, Ronald M. Krauss et al. · European Heart Journal · 2020 · 1.5K citations